Below are some of the most frequently asked questions about Halyard Health, Inc. If you do not find what you are looking for, please contact us directly.
June 1, 2018, Halyard Health, Inc. - which was incorporated in Delaware on February 25, 2014 for the purpose of holding Kimberly-Clark’s health care business following the distribution - announced the business’ rebranding to Avanos Medical, Inc. ("Avanos"). The name change became effective June 30, 2018.
Derived from the words "advanced" and "innovation," the name and brand emphasize the company's focus on innovating with speed to deliver better, more sustainable patient outcomes.
Halyard Health changed its name to Avanos Medical, Inc., effective June 30, 2018. Its previous ticker symbol on the New York Stock Exchange (HYH) also changed at that time to AVNS. The first day of trading under the AVNS ticker symbol was July 2, 2018.
Shares can be purchased through a stockbroker of your choice.
Our common stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol “AVNS”.
You can view our Board of Directors by visiting the Investors section of our website, then click Corporate Governance.
You can view our management team by visiting the Investors section of our website, then click Corporate Governance.
Avanos Medical does not currently pay dividends, as a result the company also does not offer a dividend reinvestment program (DRIP).
Our fiscal year ends on December 31st
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940
Deloitte & Touche, LLP
5405 Windward Parkway
Suite 100, South
Alpharetta, Georgia 30004
You can contact Halyard’s investor relations team via email Dave.Crawford@AVANOS.com by or by calling (770) 587-8938.